BACKGROUND. Regeneration of adult tissues requires the activity of rare, mitotically
Introduction
Adult tissues with the capacity to regenerate do so by virtue of their somatic stem cells.
The regeneration of skeletal muscle is facilitated by normally quiescent muscle stem cells (MuSCs), or "satellite cells", named for their satellite position beneath the basal lamina of the myofibre [1] , which are essential for post-natal repair of skeletal muscle [2] [3] [4] [5] . Quiescent MuSCs normally express PAX7 and, in a subset of body muscle, PAX3 [6] . In response to injury, MuSCs activate the cell cycle and the expression of members of the myogenic regulatory family of transcription factors (MYF5, MYOD). MuSCs proliferate, differentiate to repair the injured muscle, and self-renew to re-establish the MuSC pool.
The niche plays an important role in maintaining MuSCs and isolation of MuSCs from their in vivo niche rapidly influences gene expression [7, 8] . Furthermore, ex vivo culture of MuSCs results in their rapid entry into the myogenic program and loss of MuSC regenerative capacity [7] . Efforts to understand biophysical and molecular cues that regulate quiescence have been useful to mitigate the loss of MuSC regenerative capacity during ex vivo culture [8] [9, 10] [11]. We have shown that the phosphorylation of eIF2α is a translational control mechanism regulating MuSC quiescence and self-renewal. Activated MuSCs dephosphorylate eIF2α, increase protein synthesis, and rapidly activate the myogenic program. Pharmacological inhibition of the eIF2α phosphatase Gadd34/PP1 by the small compound sal003 [12] , a more potent derivative of salubrinal [13] , permits the ex vivo expansion of MuSCs that retain regenerative capacity, as illustrated by engraftment into the Dmd mdx mouse model of Duchenne muscular dystrophy [10] .
While salubrinal had been identified as a selective inhibitor of Gadd34/PP1 [13] , the molecular mechanisms underlying its inhibition, and furthermore the mechanisms underlying the increased potency of sal003 [12] remain unclear. Previous structure activity relations (SAR) demonstrate that the tricholoromethyl groups of salubrinal are essential for activity, while the quinolone ring terminus is recognized as a key site for modification (R 2 group) [14, 15] Replacement of the R 2 N-terminal quinolyl group of salubrinal with 4-chlorophenyl led to the more potent sal003 derivative [12] .
Here, we ask whether the chemical structure of sal003 can be further modified to improve efficacy, concentrating on the 4-chlorophenyl group that replaced the quinolyl group of the parent salubrinal molecule. We identify a novel analogue of sal003 that expands MuSCs ex vivo at lower concentration. We also demonstrate culture conditions containing the novel sal003
analogue permit ex vivo expansion, passaging and genome modification of primary adult MuSCs.
Results

Identification of novel sal003 analogs maintaining P-eIF2α and promoting
MuSC expansion ex vivo
To identify more efficacious analogues of sal003, we synthesized a library of derivatives ( Figure 1 ). Using a modified route previously described [15] , a panel of analogues bearing electronically and sterically diverse substituents at R 2 , which corresponds to the region of sal003 that was modified to improve efficacy, were synthesized. Aside from C8, all analogues were comprised of the trichloromethyl (-CCl 3 ) core as this functional group had previously been shown to be crucial for activity [14, 15] . With this in mind, a variety of thiourea-based aryl groups were incorporated at R 2 containing both electron-donating and withdrawing groups at differing positions.
To screen our panel of novel compounds for activity, we constructed a plasmid vector containing the 5'UTR of Atf4, which contain two open reading frames that control Atf4 mRNA translation in a P-eIF2α dependent manner [16] , fused to a firefly luciferase reporter (Fig. 2a) .
293 cells were transiently transfected with the Atf4-fluc reporter, and treated with sal003 and our panel of novel compounds. We identified four hits that increased P-eIF2α dependent translation of the Atf4-fluc reporter above levels achieved by sal003, of which compound 10 (C10) is identified as our lead compound (Fig. 2B ). C10 has a 3,5-bis(trifluoromethyl) substituted for the p-chloro on the sal003 N-phenyl group at R 2 ( Fig. 1) . Next, we used a quantitative Alpha assay in C2C12 myoblasts to directly determine eIF2α levels after exposure to sal003, C10, a subset of compounds that did not increase translation of Atf4-luc reporter (C4, C5, C9 and C11) and 100nM thapsigargin (an ER stress inducer that elevates P-eIF2α). Exposure to C10 resulted in significantly increased levels of P-eIF2α compared to sal003 (Fig. 2c) , and these results were confirmed by quantitative western blotting of the P-eIF2α to total eIF2α ratio (Fig. 2d) .
Next, we monitored the ability of novel compounds to expand ex vivo MuSCs isolated from skeletal muscle of adult Tg(Cag-luc-GFP) mice, where the expansion of colonies can be observed by bioluminescence (Fig. 2e) . Interestingly, one novel compound, C9, which has an ohydroxyl substituted for the p-chloro on the sal003 N-phenyl group at R 2 ( Fig. 1) , caused a rapid increase in bioluminescence (Fig. 2e ), without increasing P-eIF2α dependent Atf4-luc translation (Fig. 2b) or P-eIF2α levels (Fig. 2c ). Meanwhile our lead compound, C10, resulted in poor MuSC expansion at 10μM. We reasoned that excessively high P-eIF2α levels in the presence of 10μM C10 would account for an overall decrease in bioluminescence by promoting lower rates of proliferation, as we have previously shown for sal003 [10] . We therefore titrated C10 and sal003 from 10μM to 100nM to show that 5μM C10 potently expands MuSCs (Fig. 2f) at PeIF2α levels that are more equivalent to 10μM sal003 (Fig. 2d) . In contrast, 5μM sal003 does not expand MuSCs ex vivo (Fig. 2f) . 
Maintaining primary myoblasts from isolated MuSCs in the presence of C10
Primary myoblasts have limited replicative potential, are prone to differentiation, and eventually become senescent in culture. We therefore wanted to determine whether culture conditions including 5μM C10 can extend the utility of primary myoblasts from isolated MuSCs.
Isolated MuSCs were seeded on 35mm culture dishes (7500 cells/plate) and cultured in the presence of 5μM C10 or under normal conditions. Every three days, cells were passaged at a density of 1000 cells per 35mm plate. 7500 MuSCs cultured in the presence of 5μM C10 or 10μM sal003 yielded greater than 3 million cells after three passages, compared to an average of 230 000 cells remaining after a maximum of two passages under normal culture conditions ( Fig.   5a ). After 2 passages, the fraction of PAX7(+) cells is increased by three-fold in the presence of 5μM C10, while the number of MYOGENIN(+) cells is decreased (Fig. 5b, c) . After one single passage, extended culture of primary myoblasts in the presence of C10 leads to their eventual differentiation and fusion into myotubes that are larger in diameter ( Fig. 5d ) and exhibit a higher fusion index (number of DAPI counterstained nuclei per myotube) than normal culture conditions ( Fig. 5d, e) . Even under these extended culture conditions, the number of PAX7(+) cells that are associated with myotubes are increased 3-fold in the presence of C10 (Fig. 5d, f) . Fig. 6a, b) , a two-fold increase in the total number of PAX7(+) nuclei and a two-fold decrease in MYOGENIN(+) nuclei (Fig. 6c, d ). only 100 000 cells after a maximum of two passages under normal culture conditions (Fig. 6d) .
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After 2 passages, the fraction of PAX7(+) mdx cells is increased in the presence of C10, while the number of MYOGENIN(+) mdx cells is decreased (Fig. 6e, f) .
Conclusions
Here we have reported a novel compound that expands wild-type and Dmd mdx MuSCs ex vivo, enabling their engraftment in vivo, transduction with lentivirus and passaging. Further optimization of sal003/C10 analogs may facilitate the development of cell-based therapies for muscle disease, or potentially overcome defects in endogenous MuSC expansion in vivo, which would be expected to delay the progression of muscle disease.
Materials and Methods
Compounds
All chemicals and solvents were purchased from Sigma Aldrich, Alfa Aesar, TCI, or Oakwood
Chemicals. All solvents were dried and purified using an MBraun MB SPS 800 or Innovative
Technology PureSolv MD 7. Unless otherwise stated, reactions were performed in flame-dried glassware under a nitrogen or argon atmosphere. Column chromatography was conducted using 200-400 mesh silica gel from Silicycle. Atf4-pGL3 plasmid and pRL-TK renilla luciferase plasmid were co-transfected into these cells using jetPRIME® transfection reagent and incubated overnight. Compounds were reconstituted in DMSO and added to the cells for 16 hours at 10uM final concentration. Cells were then lysed and luciferase expression was measured using the Promega Dual-Luciferase Reporter kit.
P-eIF2α levels were measured using the AlphaScreen® SureFire® eIF2α (P-Ser51) assay kit. C2C12 cells were added to 96-well plates at a density of 5,000 cells/well, and cultured for 24
hours. Compounds were added at a concentration of 10uM for 4 hours and then cells were lysed and lysates were transferred to a 384-well plate. Acceptor beads were incubated with cell lysates at room temperature for 1 hour, and then donor beads were added and incubated overnight at room temperature in darkness. Emission signal was recorded using a PerkinElmer EnVision plate reader. 
Luciferase expansion assay
Passaging MuSCs
MuSCs were isolated by FACS as previously described and plated on 35mm gelatin-coated dishes at a density of 7500 cells/plate. After 3 days in culture, cells were washed with PBS once and trypsinized with 0.05% trypsin at 37°C for 1 minute. Cells were resuspended in 1ml 10%
FBS, F12 media and centrifuged at 600g for 10 minutes at 4°C. Pellets were resuspended in 100μl MuSC media, counted with a haemocytometer and plated at 2000 cells/plate for wild-type and 1000 cells/plate for Dmd mdx . Cells were subsequently passaged every 2 days, following the same protocol.
Statistical analysis
Graphical analysis is presented as mean ± SEM. At least three independent replicates of each experiment were performed. Unless otherwise indicated, significance was calculated using unpaired Student's t tests with two-tailed p values: *p < 0.05, **p < 0.01, ***p < 0.001. 
Figure Legends
